HOOKIPA Pharma Inc. (NASDAQ: HOOK)
$6.47
-0.1300 ( -1.97% ) 4.5K
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
Market Data
Open
$6.47
Previous close
$6.60
Volume
4.5K
Market cap
$64.61M
Day range
$6.40 - $6.59
52 week range
$4.10 - $11.30
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 78 | May 09, 2024 |
8-k | 8K-related | 15 | May 09, 2024 |
ars | Annual reports | 1 | Apr 26, 2024 |
def | Proxies and info statements | 4 | Apr 26, 2024 |
8-k | 8K-related | 15 | Apr 25, 2024 |
4 | Insider transactions | 1 | Apr 17, 2024 |
4 | Insider transactions | 1 | Apr 17, 2024 |
4 | Insider transactions | 1 | Apr 17, 2024 |
4 | Insider transactions | 1 | Apr 17, 2024 |
4 | Insider transactions | 1 | Apr 17, 2024 |